EUBREAST

A special thanks to all our members, supporters, patients, and friends.
wishes you a healthy and happy 2026!

is excited to share that is teaming up with Hamdi Foundation for a meeting on:
🗓 5th and 6th of February in Brussels, Belgium
✔ Get a 10% discount using the code IBREASTBOOK2
🧾 Abstract submission is open
🔗 https://www.medimeet.be/event/boobs-ii-3/page/introduction-boobs-copy

Please join Chairman Thorsten Kuehn in a Knowture webinar organized by our colleague and member, Khaled Mohamed Abdel Wahab, next Monday 27 October at 18.00 CET = 20.00 EEST = 13.00 EST.
Dra. Lia Pamela Rebaza Vasquez will be participating as a Speaker together with Prof Maria Luisa Gasparri and Prof Toralf Reimer.

🎗️ Knowture Webinar — “Recent Updates in Breast Cancer Management”
Join Knowture for our first scientific webinar featuring leading experts from Egypt, Germany, Switzerland, and Peru. The session will discuss the latest clinical evidence and surgical advances in breast cancer care.

🗓️ Date: Monday, 27 October 2025
⏰ Time: 8:00 – 9:30 PM (EET, Egypt)
📍 Platform: Online via Zoom

👥 Chairs: Prof. Thorsten Kuehn — Head of Breast Center, Die Filderklinik (Germany) & Prof. Khaled Abdelwahab — Professor of Surgical Oncology, Mansoura Oncology Center (Egypt)
🔎 Key topics:
• Axillary surgery after SOUND & INSEMA
• Tumor localization techniques (MELODY)
• Axillary management after chemotherapy (AXSANA)
• Key takeaways from ESMO 2025

🎯 Who should attend: Oncologists, breast surgeons, clinicians, and researchers interested in the latest surgical updates.
🖱️ Register for free: https://bit.ly/4nWNfF3
📧 Contact: [email protected]

🎗️ ويبنار نوتشر | الجديد في إدارة سرطان الثدي
تدعوكم منصة نوتشر (Knowture) لحضور أول ويبنار علمي متخصص بعنوان الجديد في علاج سرطان الثدي — جلسة علمية تضم نخبة من الأطباء والخبراء من مصر ، ألمانيا، سويسرا، وبيرو.

🗓️ التاريخ: الإثنين 27 أكتوبر 2025
⏰ الوقت: 8:00 — 9:30 مساءً (بتوقيت مصر)
📍 المكان: أونلاين عبر Zoom

👥 رؤساء الجلسة: البروفيسور Thorsten Kuehn (Head of Breast Center, Filderklinik, ألمانيا) & البروفيسور Khaled Abdelwahab (Professor of Surgical Oncology, Mansoura Oncology Center, مصر

📌 محاور الجلسة:
• جراحة الغدد تحت الإبط بعد SOUND وINSEMA
• تقنيات تحديد موضع الورم (MELODY)
• جراحات الغدد تحت الإبط بعد العلاج الكيماوي (AXSANA)
• أهم ما ورد في مؤتمر ESMO 2025

🎯 لمن الموجَّه؟ أطباء الأورام، جراحي الثدي، الممارسون والباحثون والراغبون في متابعة أحدث التحديثات السريرية.
🖱️ سجّل مجانًا الآن: https://bit.ly/4nWNfF3
📧 للاستفسار: [email protected]

🚨 NEW STUDY ALERT! 🚨

Recent data from the international ( ) study sheds critical light on the diagnostic performance of axillary ultrasound (AUS) after neoadjuvant chemotherapy (NACT) in initially node-positive breast cancer.

The article is now published in the European Journal of Cancer Elsevier.

📌 Key findings from 3,260 patients:

✅ AUS showed a specificity of 78.9%

⚠️ Sensitivity was only 46.4% - 35.7% of patients with negative AUS still had nodal disease

🧬 Diagnostic accuracy varied significantly by tumor subtype, grade, and breast response

📣 Bottom line: US alone is not reliable enough to determine surgical strategy after NACT. Axillary surgery remains essential for accurate staging in cN+ patients. HOWEVER, our findings suggest that AUS continues to play a role in guiding surgical staging in this context, provided its results are interpreted considering the tumor subtype, grade, and breast tumor response.

🔗 Read the full publication: https://doi.org/10.1016/j.ejca.2025.115607

🙏 Huge thanks to the entire study team, 288 study sites across 26 countries, and all our collaborators and sponsors.

This work was supported by AGO-B, the Claudia von Schilling Foundation, Ehmann Foundation Savognin, AWOgyn, Endomag, A Hologic Company, Merit Medical Systems, and Mammotome.

This milestone in axillary management would not be possible without your commitment!

🚨 Milestone Alert 🚨

and are thrilled to welcome the first study site in South Africa 🇿🇦 to the trial🙌

Thank you Mediclinic Morningside Hospital (Johannesburg) and Dr. Sarah Nietz for your work in making this exciting new collaboration happen🙏🏻

For more information, please visit: https://www.eubreast.org/melody/

🚨 NEW STUDY ALERT! 🚨

The international ( ) study brings new clarity to the clinical impact of lost axillary markers after neoadjuvant systemic therapy in breast cancer.

The article was recently published in the European Journal of Surgical Oncology.

📌 Key findings from 1,528 patients:
✅ Marker loss occurred in only 5.8% of cases
✅ Highest loss rate with metal clips (7.0%), none with radioactive seeds (0.0%)
✅ No significant increase in axillary recurrence observed after ~22 months average follow-up

📣 Bottom line: Marker loss is rare but highly dependent on technique and experience. Clinical decision-making must be tailored accordingly.

🔗 Read the full open-access publication: https://doi.org/10.1016/j.ejso.2025.110253

🙏 Huge thanks to the entire study team, all investigators across 288 study sites in 26 countries, and all our incredible collaborators and sponsors.

This study was supported by the AGO Breast Study Group (AGO-B), the Claudia von Schilling Foundation for Breast Cancer Research, the Ehmann Foundation Savognin, Eugen and Irmgard Hahn Foundation, Arbeitsgemeinschaft für ¨asthetische, plastische und wiederherstellende Operationsverfahren in der Gyn¨akologie e.V. (AWOgyn), EndoMag, Merit Medical, and Mammotome.

This incredible work would not be possible without your dedication!

🔔 EUBREAST is proud to support the PartBreCon-Pro Study! 🔬

This international, prospective, multi-centre study is focused on partial breast reconstruction using chest wall perforator flaps (CWPF) following breast-conserving surgery for early breast cancer.

📌 Key objectives:
✔ Evaluate the impact of surgery on the clinical outcome
✔ Evaluate the impact of radiotherapy on the clinical outcome
✔ Measure patient-reported outcomes (PROMs)

📆 Study duration: July 2023 – June 2028
🧾 ClinicalTrials.gov: NCT06728527(https://clinicaltrials.gov/study/NCT06728527)

🧑‍🤝‍🧑 Collaborators across Europe and beyond are invited to join! If your center performs partial breast reconstruction using CWPF, join us to improve surgical techniques & patient outcomes worldwide.

📩 Get involved today - join the PartBreCon-Pro Study led by Dr. Amit Agrawal! Contact the study team at [email protected]

🌐 Learn more: https://www.eubreast.org/partbrecon-pro-study-eubreast-supported/

🌍 Together, we aim to advance oncoplastic breast surgery through high-quality data and shared learning!